Perucca E, Beghi E, Dulac O, Shorvon S, Tomson T. Assessing risk to benefit ratio in antiepileptic drug therapy. Epilepsy Res. 2000;41(2):107–39.
Article
CAS
PubMed
Google Scholar
Anderson GD. Children versus adults: pharmacokinetic and adverse-effect differences. Epilepsia. 2002;43 Suppl 3:53–9.
Article
CAS
PubMed
Google Scholar
Cates M, Powers R. Concomitant rash and blood dyscrasias in geriatric psychiatry patients treated with carbamazepine. Ann Pharmacother. 1998;32(9):884–7.
Article
CAS
PubMed
Google Scholar
Harms SL, Eberly LE, Garrard JM, Hardie NA, Bland PC, Leppik IE. Prevalence of appropriate and problematic antiepileptic combination therapy in older people in the nursing home. J Am Geriatr Soc. 2005;53(6):1023–8.
Article
PubMed
Google Scholar
Johnson TN. The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children. Toxicology. 2003;192(1):37–48.
Article
CAS
PubMed
Google Scholar
Chalasani N, Bjornsson E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology. 2010;138(7):2246–59.
Article
CAS
PubMed
PubMed Central
Google Scholar
Njoku DB, Greenberg RS, Bourdi M, Borkowf CB, Dake EM, Martin JL, et al. Autoantibodies associated with volatile anesthetic hepatitis found in the sera of a large cohort of pediatric anesthesiologists. Anesth Analg. 2002;94(2):243–9.
PubMed
Google Scholar
Cho J, Kim L, Li Z, Rose NR, Talor MV, Njoku DB. Sex bias in experimental immune-mediated, drug-induced liver injury in BALB/c mice: suggested roles for Tregs, estrogen, and IL-6. PLoS One. 2013;8(4):e61186.
Article
CAS
PubMed
PubMed Central
Google Scholar
Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl. 2004;10(8):1018–23.
Article
PubMed
Google Scholar
Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137(12):947–54.
Article
PubMed
Google Scholar
Amacher DE. Female gender as a susceptibility factor for drug-induced liver injury. Hum Exp Toxicol. 2013;33(9):928–39.
Article
PubMed
Google Scholar
Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Pachkoria K, Garcia-Ruiz E, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005;129(2):512–21.
Article
PubMed
Google Scholar
Carey EJ, Vargas HE, Douglas DD, Balan V, Byrne TJ, Harrison ME, et al. Inpatient admissions for drug-induced liver injury: results from a single center. Dig Dis Sci. 2008;53(7):1977–82.
Article
PubMed
Google Scholar
Lucena MI, Andrade RJ, Kaplowitz N, Garcia-Cortes M, Fernandez MC, Romero-Gomez M, et al. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Hepatology. 2009;49(6):2001–9.
Article
PubMed
Google Scholar
Kwekel JC, Desai VG, Moland CL, Branham WS, Fuscoe JC. Age and sex dependent changes in liver gene expression during the life cycle of the rat. BMC Genomics. 2010;11:675.
Article
PubMed
PubMed Central
Google Scholar
Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 2002;21(17):4663–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Macrae IJ, Zhou K, Li F, Repic A, Brooks AN, Cande WZ, et al. Structural basis for double-stranded RNA processing by Dicer. Science. 2006;311(5758):195–8.
Article
CAS
PubMed
Google Scholar
Kawamata T, Making TY, RISC. Trends Biochem Sci. 2010;35(7):368–76.
Article
CAS
PubMed
Google Scholar
Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79:351–79.
Article
CAS
PubMed
Google Scholar
Palmero EI, de Campos SG, Campos M, de Souza NC, Guerreiro ID, Carvalho AL, et al. Mechanisms and role of microRNA deregulation in cancer onset and progression. Genet Mol Biol. 2011;34(3):363–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Garofalo M, Croce CM. microRNAs: master regulators as potential therapeutics in cancer. Annu Rev Pharmacol Toxicol. 2011;51:25–43.
Article
CAS
PubMed
Google Scholar
Wei J, Xie L, Taron M, Rosell R, Liu B. Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies. Drug News Perspect. 2010;23(10):655–61.
Article
CAS
PubMed
Google Scholar
Kerr TA, Korenblat KM, Davidson NO. MicroRNAs and liver disease. Transl Res. 2011;157(4):241–52.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bala S, Marcos M, Szabo G. Emerging role of microRNAs in liver diseases. World J Gastroenterol. 2009;15(45):5633–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Reid G, Kirschner MB, van Zandwijk N. Circulating microRNAs: association with disease and potential use as biomarkers. Crit Rev Oncol Hematol. 2011;80(2):193–208.
Article
PubMed
Google Scholar
Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, Shi Y, et al. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 2011;106(9):1663–9.
Article
CAS
PubMed
Google Scholar
Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One. 2011;6(8):e23937.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fukushima T, Hamada Y, Yamada H, Horii I. Changes of micro-RNA expression in rat liver treated by acetaminophen or carbon tetrachloride--regulating role of micro-RNA for RNA expression. J Toxicol Sci. 2007;32(4):401–9.
Article
CAS
PubMed
Google Scholar
Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A. 2009;106(11):4402–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Salminen WF, Yang X, Mendrick DL. Using microRNA as biomarkers of drug-induced liver injury. J Mol Biomark Diagn. 2011;2(5):1–8.
Google Scholar
Vrijens K, Bollati V, Nawrot TS. microRNAs as potential signatures of environmental exposure or effect: a systematic review. Environ Health Perspect. 2015;123(5):399–411.
CAS
PubMed
PubMed Central
Google Scholar
Hornby RJ, Starkey Lewis P, Dear J, Goldring C, Park BK. MicroRNAs as potential circulating biomarkers of drug-induced liver injury: key current and future issues for translation to humans. Expert Rev Clin Pharmacol. 2014;7(3):349–62.
Article
CAS
PubMed
Google Scholar
Li N, Muthusamy S, Liang R, Sarojini H, Wang E. Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1. Mech Ageing Dev. 2011;132(3):75–85.
Article
CAS
PubMed
Google Scholar
Kwekel JC, Vijay V, Desai VG, Moland CL, Fuscoe JC. Age and sex differences in kidney microRNA expression during the life span of F344 rats. Biol Sex Differ. 2015;6(1):1.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang J, Liu Q, Zhang W, Li J, Li Z, Tang Z, et al. Comparative profiling of genes and miRNAs expressed in the newborn, young adult, and aged human epididymides. Acta Biochim Biophys Sin (Shanghai). 2010;42(2):145–53.
Article
CAS
Google Scholar
Sharma S, Eghbali M. Influence of sex differences on microRNA gene regulation in disease. Biol Sex Differ. 2014;5(1):3.
Article
PubMed
PubMed Central
Google Scholar
de Lencastre A, Pincus Z, Zhou K, Kato M, Lee SS, Slack FJ. MicroRNAs both promote and antagonize longevity in C. elegans. Curr Biol. 2010;20(24):2159–68.
Article
PubMed
PubMed Central
Google Scholar
Kato M, Chen X, Inukai S, Zhao H, Slack FJ. Age-associated changes in expression of small, noncoding RNAs, including microRNAs, in C. elegans. RNA. 2011;17(10):1804–20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Smith-Vikos T, Slack FJ. MicroRNAs and their roles in aging. J Cell Sci. 2012;125(Pt 1):7–17.
Article
CAS
PubMed
PubMed Central
Google Scholar
Maes OC, An J, Sarojini H, Wang E. Murine microRNAs implicated in liver functions and aging process. Mech Ageing Dev. 2008;129(9):534–41.
Article
CAS
PubMed
Google Scholar
Morgan CP, Bale TL. Sex differences in microRNA regulation of gene expression: no smoke, just miRs. Biol Sex Differ. 2012;3(1):22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Waxman DJ, O’Connor C. Growth hormone regulation of sex-dependent liver gene expression. Mol Endocrinol. 2006;20(11):2613–29.
Article
CAS
PubMed
Google Scholar
Zhang Y, Wu L, Wang Y, Zhang M, Li L, Zhu D, et al. Protective role of estrogen-induced miRNA-29 expression in carbon tetrachloride-induced mouse liver injury. J Biol Chem. 2012;287(18):14851–62.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen PJ, Yeh SH, Liu WH, Lin CC, Huang HC, Chen CL, et al. Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis. Hepatology. 2012;56(2):632–43.
Article
CAS
PubMed
Google Scholar
Liang QL, Chen GQ, Li ZY, Wang BR. Function and histopathology of a cell adhesion molecule TSLC1 in cancer. Cancer Invest. 2011;29(2):107–12.
Article
PubMed
Google Scholar
Goodman DG, Maronpot RR, Newberne PM, Popp JA, Squire RA. Proliferation and selected other lesions in the liver of rats. Guides for toxologic pathology. Washington: STP/ARP/AFIP; 1994.
Google Scholar
National Toxicology Program. Toxicology and carcinogenesis studies of acrylamide (CASRN 79-06-1) in F344/N rats and B6C3F1 mice (feed and drinking water studies). Natl Toxicol Program Tech Rep Ser. 2012;(575):1-234.
Fang H, Harris SC, Su Z, Chen M, Qian F, Shi L, et al. ArrayTrack: an FDA and public genomic tool. Methods Mol Biol. 2009;563:379–98.
Article
CAS
PubMed
Google Scholar
Tong W, Cao X, Harris S, Sun H, Fang H, Fuscoe J, et al. ArrayTrack--supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ Health Perspect. 2003;111(15):1819–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
FDA. ArrayTrack- a microarray database, data analysis and interpretation tool 2016. Available from: http://www.fda.gov/ScienceResearch/BioinformaticsTools/Arraytrack/default.htm. Accessed 10 Nov 2016.
Vlachos IS, Paraskevopoulou MD, Karagkouni D, Georgakilas G, Vergoulis T, Kanellos I, et al. DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions. Nucleic Acids Res. 2015;43(Database issue):D153–9.
Article
PubMed
Google Scholar
Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T. miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res. 2009;37(Database issue):D105–10.
Article
CAS
PubMed
Google Scholar
National Toxicology Program NIEHS, NIH. Nonneoplastic Lesion Atlas, Liver - Focus 2015 [updated June 19, 2014]. Available from: http://ntp.niehs.nih.gov/nnl/hepatobiliary/liver/foci/index.htm. Accessed 10 Nov 2016.
National Toxicology Program NIEHS, NIH. Historical Controls 2015 [updated January 2, 2015]. Available from: http://ntp.niehs.nih.gov/results/dbsearch/historical/index.html. Accessed 10 Nov 2016.
Ghorai A, Ghosh U. miRNA gene counts in chromosomes vary widely in a species and biogenesis of miRNA largely depends on transcription or post-transcriptional processing of coding genes. Front Genet. 2014;5:100.
Article
PubMed
PubMed Central
Google Scholar
Qin W, Chung AC, Huang XR, Meng XM, Hui DS, Yu CM, et al. TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol. 2011;22(8):1462–74.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xiao J, Meng XM, Huang XR, Chung AC, Feng YL, Hui DS, et al. miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol Ther. 2012;20(6):1251–60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang J, Chu ES, Chen HY, Man K, Go MY, Huang XR, et al. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway. Oncotarget. 2014;6(9):7325–38.
Article
PubMed Central
Google Scholar
He Y, Huang C, Lin X, Li J. MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases. Biochimie. 2013;95(7):1355–9.
Article
CAS
PubMed
Google Scholar
Feng YY, Xu XQ, Ji CB, Shi CM, Guo XR, Fu JF. Aberrant hepatic microRNA expression in nonalcoholic fatty liver disease. Cell Physiol Biochem. 2014;34:1983–97.
Article
CAS
PubMed
Google Scholar
Huang H, Hu M, Li P, Lu C, Li M. Mir-152 inhibits cell proliferation and colony formation of CD133 liver cancer stem cells by targeting KIT. Tumour Biol. 2014;36(2):921–8.
Article
CAS
PubMed
Google Scholar
Kandi R, Gutti U, Saladi RG, Gutti RK. MiR-125b and miR-99a encoded on chromosome 21 co-regulate vincristine resistance in childhood acute megakaryoblastic leukemia. Hematol Oncol Stem Cell Ther. 2014;8(2):95–7.
Article
PubMed
Google Scholar
Li X, Zheng J, Chen L, Diao H, Liu Y. Predictive and prognostic roles of abnormal expression of tissue miR-125b, miR-221, and miR-222 in glioma. Mol Neurobiol. 2014;53(1):577–83.
Article
PubMed
Google Scholar
Li P, Sheng C, Huang L, Zhang H, Cheng Z, Zhu Q. MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration. Breast Cancer Res. 2014;16(6):473.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yang M, Liu R, Li X, Liao J, Pu Y, Pan E, et al. miRNA-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting PDCD4. Mol Cells. 2014;37(12):873–80.
Article
PubMed
PubMed Central
Google Scholar
Benetatos L, Hatzimichael E, Londin E, Vartholomatos G, Loher P, Rigoutsos I, et al. The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis. Cell Mol Life Sci. 2013;70(5):795–814.
Article
CAS
PubMed
Google Scholar
Benetatos L, Vartholomatos G, Hatzimichael E. DLK1-DIO3 imprinted cluster in induced pluripotency: landscape in the mist. Cell Mol Life Sci. 2014;71(22):4421–30.
Article
CAS
PubMed
Google Scholar
Labialle S, Marty V, Bortolin-Cavaille ML, Hoareau-Osman M, Pradere JP, Valet P, et al. The miR-379/miR-410 cluster at the imprinted Dlk1-Dio3 domain controls neonatal metabolic adaptation. EMBO J. 2014;33(19):2216–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gururajan M, Josson S, Chu GC, Lu CL, Lu YT, Haga CL, et al. miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer. Clin Cancer Res. 2014;20(24):6559–69.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu L, Luo GZ, Yang W, Zhao X, Zheng Q, Lv Z, et al. Activation of the imprinted Dlk1-Dio3 region correlates with pluripotency levels of mouse stem cells. J Biol Chem. 2010;285(25):19483–90.
Article
CAS
PubMed
PubMed Central
Google Scholar
Janssen R, Zuidwijk M, Muller A, Mulders J, Oudejans CB, Simonides WS. Cardiac expression of deiodinase type 3 (Dio3) following myocardial infarction is associated with the induction of a pluripotency microRNA signature from the Dlk1-Dio3 genomic region. Endocrinology. 2013;154(6):1973–8.
Article
CAS
PubMed
Google Scholar
Boi M, Zucca E, Inghirami G, Bertoni F. PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas. Leuk Lymphoma. 2015;56(5):1223–8.
Article
CAS
PubMed
Google Scholar
Nutt SL, Fairfax KA, Kallies A. BLIMP1 guides the fate of effector B and T cells. Nat Rev Immunol. 2007;7(12):923–7.
Article
CAS
PubMed
Google Scholar
Figueiredo JF, Mattix ME, Papenfuss TL. Hematopoietic System. In: Parker GA, Picut CA, editors. Atlas of Histology of the Juvenile Rat. 1st ed. New York: Elsevier Science; 2016. p. 349-71.
Rokavec M, Li H, Jiang L, Hermeking H. The p53/miR-34 axis in development and disease. J Mol Cell Biol. 2014;6(3):214–30.
Article
CAS
PubMed
Google Scholar
Wang Y, Zhang X, Li H, Yu J, Ren X. The role of miRNA-29 family in cancer. Eur J Cell Biol. 2013;92(3):123–8.
Article
CAS
PubMed
Google Scholar
Kim IH, Kisseleva T, Brenner DA. Aging and liver disease. Curr Opin Gastroenterol. 2015;31(3):184–91.
Article
CAS
PubMed
PubMed Central
Google Scholar
Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, et al. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Oncotarget. 2015;6(21):18613–30.
Article
PubMed
PubMed Central
Google Scholar
Li HP, Zeng XC, Zhang B, Long JT, Zhou B, Tan GS, et al. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-beta. Carcinogenesis. 2013;34(11):2443–51.
Article
CAS
PubMed
Google Scholar
Yamada H, Suzuki K, Ichino N, Ando Y, Sawada A, Osakabe K, et al. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver. Clin Chim Acta. 2013;424:99–103.
Article
CAS
PubMed
Google Scholar
Li CL, Yeh KH, Liu WH, Chen CL, Chen DS, Chen PJ, et al. Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-alpha in female hepatocellular carcinoma. Int J Cancer. 2015;136(4):761–70.
Article
CAS
PubMed
Google Scholar
Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317(5834):121–4.
Article
CAS
PubMed
Google Scholar
National Toxicology Program NIEHS, NIH. Nonneoplastic Lesion Atlas, Liver, Bile duct- Hyperplasia 2015. Available from: https://ntp.niehs.nih.gov/nnl/hepatobiliary/liver/bdhyperp/liver-bile_duct_hyperplasia_508.pdf. Accessed 26 Jul 2016.
Li D, Liu X, Lin L, Hou J, Li N, Wang C, et al. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem. 2011;286(42):36677–85.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang J, Jin H, Liu H, Lv S, Wang B, Wang R, et al. MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinoma. Oncogenesis. 2014;3:e97.
Article
CAS
PubMed
PubMed Central
Google Scholar
Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis. 2010;31(5):766–76.
Article
CAS
PubMed
Google Scholar
Hailer A, Grunewald TG, Orth M, Reiss C, Kneitz B, Spahn M, et al. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration. Oncotarget. 2014;5(12):4144–53.
Article
PubMed
PubMed Central
Google Scholar
Wei W, Wanjun L, Hui S, Dongyue C, Xinjun Y, Jisheng Z. miR-203 inhibits proliferation of HCC cells by targeting survivin. Cell Biochem Funct. 2013;31(1):82–5.
Article
CAS
PubMed
Google Scholar
Chen YP, Jin X, Xiang Z, Chen SH, Li YM. Circulating MicroRNAs as potential biomarkers for alcoholic steatohepatitis. Liver Int. 2013;33(8):1257–65.
Article
CAS
PubMed
Google Scholar
Filipowicz W, Sonenberg N. The long unfinished march towards understanding microRNA-mediated repression. RNA. 2015;21(4):519–24.
Article
CAS
PubMed
PubMed Central
Google Scholar